Cardiometabolic Health in Bipolar Disorder.
作者信息
Kemp David E, Fan Jinbo
机构信息
Assistant Professor of Psychiatry, and Director, Mood & Metabolic Clinic, Case Western Reserve University, and University Hospitals Case Medical Center, Department of Psychiatry, Cleveland, OH, USA.
Assistant Professor, Department of Epidemiology and Biostatistics and Department of Psychiatry, Case Western Reserve University, School of Medicine, Department of Epidemiology and Biostatistics, Cleveland, OH.
出版信息
Psychiatr Ann. 2012 May 1;42(5):179-183. doi: 10.3928/00485713-20120507-05.
Abstract
摘要
相似文献
1
Cardiometabolic Health in Bipolar Disorder.双相情感障碍中的心脏代谢健康
Psychiatr Ann. 2012 May 1;42(5):179-183. doi: 10.3928/00485713-20120507-05.
2
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis.精神分裂症和双相情感障碍中的心脏代谢合并症、再入院情况及费用：一项真实世界分析
Ann Gen Psychiatry. 2017 Feb 10;16:9. doi: 10.1186/s12991-017-0133-7. eCollection 2017.
3
Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder.初发单相双相情感障碍患者的心脏代谢风险和 ω-3 指数。
Bipolar Disord. 2018 Nov;20(7):658-665. doi: 10.1111/bdi.12633. Epub 2018 Feb 26.
4
Risk of cardiometabolic diseases among siblings of patients with bipolar disorder.双相障碍患者的兄弟姐妹发生心血管代谢疾病的风险。
J Affect Disord. 2019 Jun 15;253:171-175. doi: 10.1016/j.jad.2019.04.094. Epub 2019 Apr 22.
5
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).双相障碍的医疗负担：来自比较双相障碍有效性的临床和健康结局倡议（CHOICE 双相）研究的结果。
Bipolar Disord. 2015 Mar;17(2):212-23. doi: 10.1111/bdi.12243. Epub 2014 Aug 16.
6
The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals.精神分裂症和心脏代谢疾病遗传易感性的重叠可以用于识别具有不同代谢特征的个体。
Sci Rep. 2021 Jan 12;11(1):632. doi: 10.1038/s41598-020-79964-x.
7
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response.双相障碍患者有严重的家族精神病史，与疾病严重程度和治疗反应相关。
J Affect Disord. 2020 Aug 1;273:131-137. doi: 10.1016/j.jad.2020.03.157. Epub 2020 May 16.
8
Correlates of treatment response in depressed older adults with bipolar disorder.双相障碍老年抑郁患者治疗反应的相关因素。
J Geriatr Psychiatry Neurol. 2012 Mar;25(1):37-42. doi: 10.1177/0891988712436685.
9
The association between meal timing and frequency with cardiometabolic profile in patients with bipolar disorder.双相情感障碍患者进餐时间和频率与心脏代谢特征之间的关联。
Acta Psychiatr Scand. 2016 Jun;133(6):453-8. doi: 10.1111/acps.12578. Epub 2016 Apr 15.
10
Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities.双相情感障碍中的医学及物质相关共病：转化研究与治疗机遇
Dialogues Clin Neurosci. 2008;10(2):203-13. doi: 10.31887/DCNS.2008.10.2/rsmcintyre.
引用本文的文献
1
PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.过氧化物酶体增殖物激活受体-γ 激动剂作为情绪调节剂：吡格列酮治疗双相抑郁的概念验证。
CNS Drugs. 2014 Jun;28(6):571-81. doi: 10.1007/s40263-014-0158-2.
本文引用的文献
1
2
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.经鼻胰岛素治疗阿尔茨海默病和遗忘型轻度认知障碍：一项试点临床试验。
Arch Neurol. 2012 Jan;69(1):29-38. doi: 10.1001/archneurol.2011.233. Epub 2011 Sep 12.
3
Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.脑胰岛素信号转导：认知过程的关键组成部分，也是 2 型糖尿病认知障碍的潜在基础。
Neurobiol Learn Mem. 2011 Oct;96(3):432-42. doi: 10.1016/j.nlm.2011.08.005. Epub 2011 Aug 30.
4
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.抗精神病药引起的体重增加的药物遗传学：综述及临床意义。
Mol Psychiatry. 2012 Mar;17(3):242-66. doi: 10.1038/mp.2011.109. Epub 2011 Sep 6.
5
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.齐拉西酮联合心境稳定剂治疗双相 I 型障碍的维持治疗：体重和代谢特征的长期变化。
Eur Neuropsychopharmacol. 2012 Feb;22(2):123-31. doi: 10.1016/j.euroneuro.2011.06.005. Epub 2011 Jul 28.
6
Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.使用胰岛素增敏剂治疗重度抑郁症：吡格列酮治疗伴有腹型肥胖的重度抑郁症的初步研究。
J Affect Disord. 2012 Feb;136(3):1164-73. doi: 10.1016/j.jad.2011.06.033. Epub 2011 Jul 22.
7
Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat.瘦素水平与体重范围内女性的抑郁症状减少有关，与体脂肪无关。
Clin Endocrinol (Oxf). 2012 Apr;76(4):520-5. doi: 10.1111/j.1365-2265.2011.04182.x.
8
Insulin dysfunction and allostatic load in bipolar disorder.双相障碍中的胰岛素功能障碍和应激负荷。
Expert Rev Neurother. 2011 Jul;11(7):1017-28. doi: 10.1586/ern.10.185.
9
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.N-乙酰半胱氨酸作为双相抑郁症辅助治疗的疗效：一项开放标签试验。
J Affect Disord. 2011 Dec;135(1-3):389-94. doi: 10.1016/j.jad.2011.06.005. Epub 2011 Jun 29.
10
Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway.吡格列酮在小鼠强迫游泳试验中的抗抑郁样作用：PPAR-γ 受体和一氧化氮途径的作用。
Behav Brain Res. 2011 Oct 31;224(2):336-43. doi: 10.1016/j.bbr.2011.06.011. Epub 2011 Jun 17.
Zotero 插件